Skip to content
Catalyst

fucoidanFinding

Fucoidan decreases total leukocyte count

lowersLimited evidenceFinding

01 · The sentence it was drawn from

“The change in WBC at 24th week (−1482.2 ± 1285.7) during supplementation with oligo-fucoidan decreased significantly more than that in the control group at 24th week (−589.0 ± 2835.0) (p = 0.038).”
Quoted verbatim from Effects of oligo-fucoidan on the immune response, inflammatory status and pulmonary function in patients with asthma: a randomized, double-blind, placebo-controlled trial.
This finding among the 13 findings on its endpoint

fucoidan

Total leukocyte count

lowers

Who
Twenty adults with allergic asthma; both arms received regular asthma treatment; change from baseline at 24 weeks
Dose studied
550 mg x 4 tablets per time, twice a day, 24 weeks, oral

Limited evidencePMID 36307493 · 2022

02 · The study

Study
RCT
Duration
6 months

Evidence, by strength

  • strong
  • moderate
  • limitedthis finding
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FQFBT422MB4RTF5WJC6P7C